Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 8 de 8
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Am J Cardiol ; 65(16): 1084-9, 1990 May 01.
Artículo en Inglés | MEDLINE | ID: mdl-2109927

RESUMEN

The hemodynamic and platelet effects of prostacyclin (PGI2) were investigated in 27 patients with unstable angina (14 treated patients; 13 control subjects) given a 72-hour infusion (5 ng/kg/min) or placebo. This randomized study was double-blind and conducted as a substudy of a multicenter trial testing the clinical efficacy of PGI2. The clinical and angiographic features were identical in the 2 groups. Blood pressure and heart rate were not modified significantly by PGI2. A recurrence of angina during infusion occurred in 8 treated patients (57.1%) and in 8 control subjects (61.5%). Two patients receiving PGI2 and none in the control group developed a myocardial infarction. Levels of 6-keto-prostaglandin F1 alpha, a stable metabolite of PGI2, increased from baseline values (less than 20 pg/ml) to 605 +/- 41 pg/ml during infusion. Levels of fibrinopeptide A, beta-thromboglobulin, platelet factor 4, thromboxane B2 and the platelet aggregates ratio in blood were similar between the 2 groups before, during and after PGI2 infusion. Prostacyclin reduced ex vivo platelet aggregation to adenosine diphosphate and thromboxane B2 generation by approximately 50% during the infusion period with return of aggregation to baseline and platelet thromboxane B2 production to above baseline after the discontinuation of PGI2. Thus, despite favorable effects of PGI2 upon platelet aggregation and systemic hemodynamics, the prostanoid failed to improve the clinical evolution of unstable angina.


Asunto(s)
Angina de Pecho/tratamiento farmacológico , Angina Inestable/tratamiento farmacológico , Plaquetas/efectos de los fármacos , Epoprostenol/uso terapéutico , Hemodinámica/efectos de los fármacos , 6-Cetoprostaglandina F1 alfa/sangre , Anciano , Angina Inestable/sangre , Angina Inestable/fisiopatología , Método Doble Ciego , Femenino , Fibrinopéptido A/metabolismo , Humanos , Masculino , Persona de Mediana Edad , Estudios Multicéntricos como Asunto , Agregación Plaquetaria/efectos de los fármacos , Inhibidores de Agregación Plaquetaria/farmacología , Factor Plaquetario 4/análisis , Ensayos Clínicos Controlados Aleatorios como Asunto , Recurrencia , Tromboxano B2/sangre
2.
Am J Pathol ; 126(3): 569-80, 1987 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-3030118

RESUMEN

Epinephrine (E), isoproterenol (I), and dopamine (D) were compared with norepinephrine (N) for production of microthrombi during thrombin-induced disseminated intravascular coagulation (DIC) in rabbits. Only catecholamines acting on alpha-adrenoreceptors produced glomerular capillary thrombosis (GCT) typical of the generalized Shwartzman reaction (GSR). Epinephrine produced GCT three times (P less than 0.05) less severe than that produced by N, but beta-blockade with propranolol (P) rendered E equal to N in potency. I and D reduced fibrinogen consumption produced by thrombin. I (0.5-0.66 microgram/kg/min), as opposed to D, prevented the GSR produced by endotoxin in the pregnant rat and the cortisone-sensitized rabbit, and P increased the severity of the GSR in the pregnant rat. Alpha-adrenergic blockade with dibenzyline prevented the GSR produced by endotoxin in rats, whether pregnant, diabetic, or having a unilateral ureteral occlusion, and the classic reaction in rabbits, but not that produced in renal-hypertensive rats. Simultaneous alpha + beta stimulations by E triggered coronary and hepatic microthrombi, which were prevented by P. It is concluded that beta-adrenergic stimulation, as opposed to D-adrenergic stimulation, counterbalances alpha-adrenergic effects occurring in endotoxemia, which are required for production of the GSR in most models. These studies stress the risks and benefits of beta-blockade and provide additional evidence for the role of vasoactive agents and microcirculatory changes on selection of target organs for production of microthrombi during DIC.


Asunto(s)
Catecolaminas/farmacología , Coagulación Intravascular Diseminada/fisiopatología , Glomérulos Renales/irrigación sanguínea , Fenómeno de Shwartzman/fisiopatología , Trombosis/fisiopatología , Animales , Plaquetas/efectos de los fármacos , Presión Sanguínea/efectos de los fármacos , Capilares/patología , Coagulación Intravascular Diseminada/complicaciones , Coagulación Intravascular Diseminada/patología , Dopamina/farmacología , Endotoxinas/toxicidad , Femenino , Fibrinógeno/análisis , Masculino , Embarazo , Propranolol/farmacología , Conejos , Ratas , Receptores Adrenérgicos beta/efectos de los fármacos , Receptores Adrenérgicos beta/fisiología , Fenómeno de Shwartzman/etiología , Fenómeno de Shwartzman/patología , Trombina/farmacología , Trombosis/etiología , Trombosis/patología
3.
Circulation ; 75(1): 156-62, 1987 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-2947740

RESUMEN

Fibrinopeptide A, platelet factor 4, beta-thromboglobulin, thromboxane B2, and 6-keto-prostaglandin F1 alpha were estimated by radioimmunoassay on venous plasma samples taken within 48 hr of admission from 16 consecutive patients with unstable angina and 15 patients with stable angina matched for clinical variables. The ratio of circulating platelet aggregates, platelet aggregation to increasing concentrations of ADP (0.455 to 1.82 micrograms/ml), and platelet thromboxane B2 production in vitro were also tested. The two groups of patients were statistically similar in terms of sex distribution, age, presence of risk factors, use of medication, extent of coronary artery disease and history of previous myocardial infarction. Mean plasma levels of fibrinopeptide A were 2.7 +/- 0.4 ng/ml (geometric means +/- SEM, range 1.5 to 5.5) in patients with stable angina vs 5.5 +/- 1.8 ng/ml (range 2.4 to 32; p less than .001) in those with unstable angina. In the latter group, after 6 to 8 days, fibrinopeptide A levels decreased to 3.6 +/- 0.5 ng/ml (range 1.5 to 9.3; p less than .04 vs admission). All other variables measured were statistically identical in the two groups. We conclude that plasma fibrinopeptide A levels, as opposed to platelet factors, discriminate between patients with unstable and stable angina, indicating an activation of the coagulation system in unstable angina.


Asunto(s)
Angina de Pecho/sangre , Angina Inestable/sangre , Fibrinógeno/análisis , Fibrinopéptido A/análisis , Factor Plaquetario 4/análisis , 6-Cetoprostaglandina F1 alfa/sangre , Adenosina Difosfato/farmacología , Angina de Pecho/diagnóstico por imagen , Angina Inestable/diagnóstico por imagen , Angiografía Coronaria , Ventrículos Cardíacos/diagnóstico por imagen , Humanos , Esfuerzo Físico , Agregación Plaquetaria/efectos de los fármacos , Tromboxano B2/sangre , Factores de Tiempo , beta-Tromboglobulina/análisis
4.
Am J Pathol ; 124(2): 187-92, 1986 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-3740212

RESUMEN

Renal cortical necrosis (RCN) has been reported in the normal kidney of patients with a contralateral ureteral occlusion (UO). So far, studies have examined the mechanisms protecting the affected kidney from glomerular thrombosis and cortical necrosis; but to the authors' knowledge, none has ever investigated the potential role of UO on the occurrence of the associated disseminated intravascular coagulation (DIC) episode leading to RCN. Female rats with a ligature of the right or left ureter were given injections, at different times after surgery, of 400 micrograms Salmonella typhosa 0901 endotoxin. Other experimental groups included normal and sham-operation rats and animals with a unilateral nephrectomy or with one kidney rendered ischemic by complete ligature of the renal vessels and of the ureter. All the animals were sacrificed 4 hours after endotoxin, and kidney sections stained with PTAH were examined for the presence of fibrin thrombi. Glomerular thrombosis was never observed in any hydronephrotic kidney, but occurred with a low incidence (16%) in the contralateral organ in the group given endotoxin the second day after UO. The incidence and severity of glomerular capillary thrombosis gradually increased in the normal kidney as the delay between surgery and endotoxin was prolonged; the incidences (P less than 0.01) were 45% and 83%, respectively, after 6 and 10 days. Endotoxin failed totally to initiate the lesion 1 day after UO as well as in normal, sham-operation and unilaterally nephrectomized rats, and in animals with combined UO and ligature of the renal circulation. We conclude that the perfused hydronephrotic kidney liberates a factor(s) that sensitizes to DIC and glomerular thrombosis, typical of the generalized Shwartzman reaction.


Asunto(s)
Fenómeno de Shwartzman/prevención & control , Obstrucción Ureteral/inmunología , Animales , Capilares , Endotoxinas/farmacología , Femenino , Inmunización , Riñón/patología , Glomérulos Renales/irrigación sanguínea , Ratas , Salmonella typhi , Trombosis/patología , Trombosis/prevención & control
5.
Pathology ; 17(3): 429-36, 1985 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-4069759

RESUMEN

The mechanism whereby norepinephrine elicits thrombosis during intravascular coagulation was investigated further in rabbits given a 4 h infusion of thrombin (1 NIH unit/kg/min). Norepinephrine (3 micrograms/kg/min) combined with thrombin produced glomerular capillary thrombosis in all animals as compared to 4.3% with thrombin alone. Alpha-adrenergic receptors mediated this effect, as indicated (a) by prevention of glomerular thrombosis by dibenzyline but not by methysergide, and (b) by failure of histamine or acetylcholine combined with thrombin to induce the phenomenon. However, in combination with thrombin, these two agents induced duodenal mucosal microthrombosis. Study of the glomerular circulation with colloidal carbon showed that norepinephrine elicits severe glomerular capillary stasis in thrombin treated rabbits; the vasomotor reaction precedes increased fibrinogen consumption and focal deposition of fibrin in the glomeruli. Pretreatment with dibenzyline prevented glomerular stasis and reduced fibrinogen consumption. The phagocytic activity of the reticulo-endothelial system was increased 7 times by thrombin infusions, with or without norepinephrine. We conclude that stimulation of the alpha 1-adrenergic receptors triggers glomerular thrombosis by production of severe glomerular stasis which localizes formation of thrombi in the dilated vessels. These results provide a rational explanation for the role of alpha-adrenergic stimulation in the endotoxin-induced generalized Shwartzman reaction and outline some of the mechanisms and agents implied in the selection of the target organs for thrombosis during intravascular coagulation.


Asunto(s)
Agregación Eritrocitaria/inducido químicamente , Norepinefrina , Trombosis/inducido químicamente , Animales , Plaquetas , Presión Sanguínea/efectos de los fármacos , Agregación Eritrocitaria/patología , Fibrinógeno/metabolismo , Granulocitos/fisiología , Glomérulos Renales/patología , Masculino , Conejos , Circulación Renal , Trombina/farmacología
6.
Pathology ; 16(4): 411-7, 1984 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-6522106

RESUMEN

Pathogenesis of the microthrombi produced during intravascular coagulation was investigated in rabbits given intravenous infusions of thrombin or adenosine diphosphate (ADP). Thrombin, at a dosage producing a fibrinogen consumption of 70% within 4 h (1 unit/kg/min), failed to produce extrapulmonary microthrombi unless fibrinolysis inhibition (epsilon-aminocaproic acid-EACA) or alpha-adrenergic stimulation (norepinephrine) were provided simultaneously. The mechanism whereby norepinephrine initiated glomerular capillary thrombosis was not related to interference with fibrinolysis nor to potentiation of platelet aggregation and blood coagulation, as indicated by similar consumption of plasminogen and platelets in animals given thrombin alone or combined with norepinephrine, and by the lack of correlation between fibrinogen consumption and the incidence and severity of glomerular thrombosis produced with various dosages (1 to 3 mu/kg/min) of norepinephrine. With norepinephrine, microthrombi were also observed in the adrenals, the spleen and the gastric mucosa. Aspirin prevented the phenomena in the latter two organs, but was inactive or aggravating on thrombogenesis elsewhere. ADP associated with thrombin failed to trigger formation of microthrombi but initiated platelet-rich thrombi in the pulmonary vasculature when associated with norepinephrine. We conclude that unlike thrombin, ADP cannot be held responsible for the microthrombi elicited during experimental intravascular coagulation. Furthermore, the ability of norepinephrine to elicit glomerular thrombosis in thrombin injected rabbits may provide an explanation for requirement of alpha-adrenergic stimulation in the endotoxin-induced generalized Shwartzman reaction.


Asunto(s)
Adenosina Difosfato/farmacología , Coagulación Sanguínea/efectos de los fármacos , Coagulación Intravascular Diseminada/sangre , Norepinefrina/farmacología , Trombina/farmacología , Trombosis/etiología , Adenosina Trifosfato/farmacología , Ácido Aminocaproico/farmacología , Animales , Aspirina/farmacología , Pruebas de Coagulación Sanguínea , Conejos , Fenómeno de Shwartzman/sangre , Trombosis/sangre
7.
Am J Obstet Gynecol ; 135(5): 577-80, 1979 Nov 01.
Artículo en Inglés | MEDLINE | ID: mdl-500776

RESUMEN

The GSR induced by a single injection of endotoxin in pregnant rats and cortisone-sensitized rabbits was prevented by bradykinin. The action is mediated by prostaglandins, such as evidenced by: (1) abolition of the effect of bradykinin by aspirin, (2) prevention of the Shwartzman reaction by infusions of PGA2 and PGE1, and (3) sensitization of the normal male rat to the generalized Shwartzman reaction by infusions of PGA2 and PGE1, and (3) sensitization of the normal male rat to the generalized Shwartzman reaction by indomethacin. The mechanism appears to be a neutralization of the essential alpha-adrenergic component of the generalized Shwartzman reaction.


Asunto(s)
Prostaglandinas/fisiología , Fenómeno de Shwartzman/fisiopatología , Animales , Aspirina/farmacología , Bradiquinina/antagonistas & inhibidores , Bradiquinina/uso terapéutico , Cortisona/uso terapéutico , Endotoxinas , Femenino , Indometacina/uso terapéutico , Masculino , Embarazo , Prostaglandinas/biosíntesis , Prostaglandinas A/fisiología , Prostaglandinas E/fisiología , Conejos , Ratas , Salmonella typhi , Fenómeno de Shwartzman/prevención & control
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA